A two-stage diagnostic model for discriminating and assessing risk of meropenem heteroresistance in Pseudomonas aeruginosa. Fan Y, Liang X, Ren Y, Nie S, et al. J Antimicrob Chemother 2026;81:dkag061.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fan Y, Liang X, Ren Y, Nie S, et al. A two-stage diagnostic model for discriminating and assessing risk of meropenem heteroresistance in Pseudomonas aeruginosa. J Antimicrob Chemother 2026;81:dkag061.
PMID: 41736572